Literature DB >> 1346307

Efficacy of cytarabine in progressive multifocal leucoencephalopathy in AIDS.

F Nicoli, B Chave, J C Peragut, J L Gastaut.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1346307     DOI: 10.1016/0140-6736(92)91376-j

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  13 in total

Review 1.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

2.  Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.

Authors:  Juliene K G Co; Saguna Verma; Ulziijargal Gurjav; Laarni Sumibcay; Vivek R Nerurkar
Journal:  J Infect Dis       Date:  2007-07-20       Impact factor: 5.226

Review 3.  AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.

Authors:  Mark T M Roberts
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.

Authors:  M J Post; C Yiannoutsos; D Simpson; J Booss; D B Clifford; B Cohen; J C McArthur; C D Hall
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

5.  Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside.

Authors:  A J Aksamit
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 6.  Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML).

Authors:  R M Levy; E Major; M J Ali; B Cohen; D Groothius
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 7.  Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Authors:  Leslie J Marshall; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

Review 8.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

9.  Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy.

Authors:  M M Thurnher; M J Post; A Rieger; C Kleibl-Popov; C Loewe; E Schindler
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

10.  Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy.

Authors:  W Royal; B Dupont; D McGuire; L Chang; K Goodkin; T Ernst; M J Post; D Fish; G Pailloux; H Poncelet; M Concha; L Apuzzo; E Singer
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.